Community Practice Connections™: Expert Perspectives on the Evolving Treatment Paradigm in Heart Failure Management

CME: 1.0

Target Audience

This educational activity is directed toward Cardiologists, Internists, Primary Care Physicians, Endocrinologists, Nephrologists, Hospitalists, Physician Assistants, Nurse Practitioners, Pharmacists, Certified Diabetes Educators.

Program Overview

Heart failure (HF) remains a leading cause of morbidity and mortality. Despite the fact that guideline-directed medical therapy (GDMT) has been shown to improve HF survival, GDMT optimization in clinical practice remains poor. Recent guideline updates have added an additional class of pharmacologic therapies as new tools for managing this disease. Continuing medical education is important for keeping clinicians who treat patients with HF informed of new standards of care and state-of-the-art management practices.

This Community Practice Connections™ program provides an in-depth review of some of the key highlights from a hybrid satellite symposium held adjunct to the Heart Failure Society of America Annual Scientific Meeting 2022, convened in October. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with HF, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Learning Objectives

Upon completion of this activity, participants should be better able to:
  • Identify diagnostic strategies for heart failure (HF)
  • Apply evidence-based guidelines for treatment selection for HF and its comorbidities
  • Outline the mechanisms of action of emerging therapies for HF
  • Differentiate clinical trial evidence for emerging therapies to manage HF

Post a comment to this article